A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali

被引:151
作者
Sagara, Issaka [1 ]
Dicko, Alassane [1 ]
Ellis, Ruth D. [2 ]
Fay, Michael P. [3 ]
Diawara, Sory I. [1 ]
Assadou, Mahamadoun H. [1 ]
Sissoko, Mahamadou S. [1 ]
Kone, Mamady [1 ]
Diallo, Abdoulbaki I. [1 ]
Saye, Renion [1 ]
Guindo, Merepen A. [1 ]
Kante, Ousmane [1 ]
Niambele, Mohamed B. [1 ]
Miura, Kazutoyo [2 ]
Mullen, Gregory E. D. [2 ,6 ]
Pierce, Mark [2 ,5 ]
Martin, Laura B. [2 ,4 ]
Dolo, Amagana [1 ]
Diallo, Dapa A. [1 ]
Doumbo, Ogobara K. [1 ]
Miller, Louis H. [2 ]
Saul, Allan [2 ,4 ]
机构
[1] Univ Bamako, Malaria Res & Training Ctr, Fac Med Pharm & Dent, Mali, Malaysia
[2] NIAID, Malaria Vaccine Dev Branch, NIH, Rockville, MD 20852 USA
[3] NIAID, Biostat Res Branch, NIH, Bethesda, MD USA
[4] Novartis Vaccines Inst Global Hlth Srl, Siena, Italy
[5] Cookeville Reg Med Ctr, Cookeville, TN 38506 USA
[6] St Thomas Hosp, Rayne Inst, Div Imaging Sci, Sch Med,Kings Coll London, London SE1 7EH, England
基金
美国国家卫生研究院;
关键词
Malaria; Vaccine; AMA1; APICAL MEMBRANE ANTIGEN-1; PLASMODIUM-FALCIPARUM; AMA-1; PROTECTION; CANDIDATE; EFFICACY; MONKEYS;
D O I
10.1016/j.vaccine.2009.03.014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
A double blind, randomized, controlled Phase 2 clinical trial was conducted to assess the safety, immunogenicity, and biologic impact of the vaccine candidate Apical Membrane Antigen 1-Combination 1 (AMA1-C1), adjuvanted with Alhydrogel (R) Participants were healthy children 2-3 years old living in or near the village of Bancoumana. Mali. A total of 300 children received either the study vaccine or the comparator. No impact of vaccination was seen on the primary endpoint, the frequency of parasitemia measured as episodes >3000/mu L/day at risk. There was a negative impact of vaccination on the hemoglobin level during clinical malaria, and mean incidence of hemoglobin <8.5 g/dL, in the direction of lower hemoglobin in the children who received AMA1-C1, although these differences were not significant after correction for multiple tests. These differences were not seen in the second year of transmission. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3090 / 3098
页数:9
相关论文
共 35 条
[1]
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children:: randomised controlled trial [J].
Alonso, PL ;
Sacarlal, J ;
Aponte, JJ ;
Leach, A ;
Macete, E ;
Milman, J ;
Mandomando, I ;
Spiessens, B ;
Guinovart, C ;
Espasa, M ;
Bassat, Q ;
Aide, P ;
Ofori-Anyinam, O ;
Navia, MM ;
Corachan, S ;
Ceuppens, M ;
Dubois, MC ;
Demoitié, MA ;
Dubovsky, F ;
Menéndez, C ;
Tornieporth, N ;
Ballou, WR ;
Thompson, R ;
Cohen, J .
LANCET, 2004, 364 (9443) :1411-1420
[2]
PROTECTIVE IMMUNITY INDUCED IN SQUIRREL-MONKEYS WITH RECOMBINANT APICAL MEMBRANE ANTIGEN-1 OF PLASMODIUM FRAGILE [J].
COLLINS, WE ;
PYE, D ;
CREWTHER, PE ;
VANDENBERG, KL ;
GALLAND, GG ;
SULZER, AJ ;
KEMP, DJ ;
EDWARDS, SJ ;
COPPEL, RL ;
SULLIVAN, JS ;
MORRIS, CL ;
ANDERS, RF .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1994, 51 (06) :711-719
[3]
Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1 [J].
Cortes, A ;
Mellombo, M ;
Mueller, I ;
Benet, A ;
Reeder, JC ;
Anders, RF .
INFECTION AND IMMUNITY, 2003, 71 (03) :1416-1426
[4]
Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes [J].
Crewther, PE ;
Matthew, MLSM ;
Flegg, RH ;
Anders, RF .
INFECTION AND IMMUNITY, 1996, 64 (08) :3310-3317
[5]
Year-to-year variation in the age-specific incidence of clinical malaria in two potential vaccine testing sites in Mali with different levels of malaria transmission intensity [J].
Dicko, Alassane ;
Sagara, Issaka ;
Diemert, David ;
Sogoba, Moussa ;
Niambele, Mohamed B. ;
Dao, Adama ;
Dolo, Guimogo ;
Yalcouye, Daniel ;
Diallo, Dapa A. ;
Saul, Allan ;
Miller, Louis H. ;
Toure, Yeya T. ;
Klion, Amy D. ;
Doumbo, Ogobara K. .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (06) :1028-1033
[6]
Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult Malians [J].
Dicko, Alassane ;
Diemert, David J. ;
Sagara, Issaka ;
Sogoba, Moussa ;
Niambele, Mohamed B. ;
Assadou, Mahamadoun H. ;
Guindo, Ousmane ;
Kamate, Beh ;
Baby, Mounirou ;
Sissoko, Mady ;
Malkin, Elissa M. ;
Fay, Michael P. ;
Thera, Mahamadou A. ;
Miura, Kazutoyo ;
Dolo, Amagana ;
Diallo, Dapa A. ;
Mullen, Gregory E. ;
Long, Carole A. ;
Saul, Allan ;
Doumbo, Ogobara ;
Miller, Louis H. .
PLOS ONE, 2007, 2 (10)
[7]
Phase 1 Study of a Combination AMA1 Blood Stage Malaria Vaccine in Malian Children [J].
Dicko, Alassane ;
Sagara, Issaka ;
Ellis, Ruth D. ;
Miura, Kazutoyo ;
Guindo, Ousmane ;
Kamate, Beh ;
Sogoba, Moussa ;
Niambele, Mohamed Balla ;
Sissoko, Mady ;
Baby, Mounirou ;
Dolo, Amagana ;
Mullen, Gregory E. D. ;
Fay, Michael P. ;
Pierce, Mark ;
Diallo, Dapa A. ;
Saul, Allan ;
Miller, Louis H. ;
Doumbo, Ogobara K. .
PLOS ONE, 2008, 3 (02)
[8]
Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children [J].
Dodoo, Daniel ;
Aikins, Anastasia ;
Kusi, Kwadwo Asamoah ;
Lamptey, Helena ;
Remarque, Ed ;
Milligan, Paul ;
Bosomprah, Samuel ;
Chilengi, Roma ;
Osei, Yaa Difie ;
Akanmori, Bartholomew Dicky ;
Theisen, Michael .
MALARIA JOURNAL, 2008, 7 (1)
[9]
Dolo A, 2003, Bull Soc Pathol Exot, V96, P308
[10]
Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1:: Implications for vaccine design [J].
Duan, Junhui ;
Mu, Jianbing ;
Thera, Mahamadou Ali ;
Joy, Deirdre ;
Pond, Sergei L. Kosakovsky ;
Diemert, David ;
Long, Carole ;
Zhou, Hong ;
Miura, Kazutoyo ;
Ouattara, Amed ;
Dolo, Amagana ;
Doumbo, Ogobara ;
Su, Xin-Zhuan ;
Miller, Louis .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (22) :7857-7862